Antifungal activity of Leptospermum petersonii oil volatiles against Aspergillus spp. in vitro and in vivo

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 2, 2009, Pages 285-288

  Hood, J R ^a,b   Burton, D ^a   Wilkinson, J M ^a   Cavanagh, H M A ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

^b Australian Capital Territory   (Australia)

Author keywords

Essential oils; L. petersonii; Volatile compounds

Indexed keywords

CHITIN; ESSENTIAL OIL; HERBACEOUS AGENT; LEPTOSPERMUM PETERSONII OIL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LEPTOSPERMUM; LEPTOSPERMUM PETERSONII; LUNG INFECTION; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; TOXICITY TESTING;

EID: 77950241877     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp400     Document Type: Article

References (14)

1. Haczku A, Atochina E, Tomer Y et al. Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol 2001; 25: 45-50.
2. Lin M, Lu H, Chen W. Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer. Clin Infect Dis 2001; 33: 1621-7.
3. BitMansour A, Cao T, Chao S et al. Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapyinduced neutropenia. Blood 2005; 105: 3535-7.
4. Utama I, Wills R, Ben-Yehoshua S et al. In vitro efficacy of plant volatiles for inhibiting the growth of fruit and vegetable decay microorganisms. J Agric Food Chem 2002; 50: 6371-7.
5. Cenci E, Mencacci A, Bacci A et al. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000; 165: 381-8.
6. Lehmann P, White L. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice. Infect Immun 1975; 12: 987-92.
7. Suhr K, Nielsen P. Antifungal activity of essential oils evaluated by two different application techniques against rye bread spoilage fungi. J Appl Microbiol 2003; 94: 665-74.
8. Hayes A, Markovic B. Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity. Food Chem Toxicol 2002; 40: 535-43.
9. Gaworski C, Vollmuth T, York R et al. Developmental toxicity evaluation of inhaled citral in Sprague-Dawley rats. Food Chem Toxicol 1992; 30: 269-75.
10. Balloy V, Huerre M, Latgé J et al. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494-503.
11. Hayashi R, Kitamoto N, Izawa Y et al. Efficacy of TAK457, a novel intravenous triazole, against invasive pulmonary aspergillosis in neutropenic mice. Antimicrob Agents Chemother 2002; 46: 283-7.
12. Vallor A, Kirkpatrick WR, Najvar LK et al. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 2008; 52: 2593-8.
13. Becker M, de Marie S, Fens M et al. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response. J Antimicrob Chemother 2002; 49: 813-20.
14. Morrison B, Park S, Mooney J et al. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003; 112: 1862-70.